Related Experiment Video

Updated: May 28, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Cardiac magnetic resonance in hypertrophic cardiomyopathy

Andrew C Y To1, Ashwat Dhillon, Milind Y Desai

  • 1Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.

JACC. Cardiovascular Imaging
|October 18, 2011
PubMed

Insights

Hypertrophic cardiomyopathy, a genetic heart condition, shows varied progression. Cardiac magnetic resonance imaging (CMR) is increasingly vital for its diagnosis, treatment planning, and predicting outcomes.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex genetic cardiovascular disorder.
  • Significant variability exists in HCM's phenotypic expression and natural progression.
  • Understanding HCM's nuances is crucial for effective patient management.

Purpose of the Study:

  • To highlight the role of cardiac magnetic resonance (CMR) in managing hypertrophic cardiomyopathy.
  • To emphasize the diagnostic, therapeutic, and prognostic utility of CMR in HCM.
  • To discuss the impact of multimodality imaging on understanding HCM's prognostic implications.

Main Methods:

  • Review of recent research on cardiac magnetic resonance in hypertrophic cardiomyopathy.
  • Analysis of the integration of multimodality imaging in clinical practice.
  • Evaluation of morphologic differences and their prognostic significance.

Main Results:

  • Cardiac magnetic resonance offers incremental value in HCM diagnosis.
  • CMR aids in therapeutic planning and prognostication for HCM patients.
  • Multimodality imaging enhances the understanding of HCM's subtle features.

Conclusions:

  • Cardiac magnetic resonance is an essential tool for hypertrophic cardiomyopathy.
  • Integrating advanced imaging improves the understanding and management of HCM.
  • Further research into imaging-based prognostic markers is warranted.

More Related Videos

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging11:13

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging

Published on: May 24, 2021

Cardiac Magnetic Resonance Imaging at 7 Tesla09:14

Cardiac Magnetic Resonance Imaging at 7 Tesla

Published on: January 6, 2019

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...